Taken together, the development of an early onset and aggressive tumor phenotype in Cdh1L/L:PtenL/L:PB-Cre4 compound mice in comparison with PtenL/L:PB-Cre4 mice demonstrates a promotional role of E-cadherin deletion in prostate tumor formation and progression. The gene discussed is CDH1; the disease is neoplasm.